Stockreport

GRI Bio Announces Pricing of $4 Million Public Offering [Yahoo! Finance]

GRI Bio, Inc.  (GRI) 
PDF innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the pricing of a pub [Read more]